TruAlt Bioenergy IPO
Historical offer record. This offer is closed for applications. Prices and subscriptions describe the past offer; GMP observations are unofficial past records, not current quotes or listing predictions.
Data provider: FinAPI. This is a third-party summary, not an official prospectus. Read our data limitations and editorial policy.
No GMP observations are available for this historical offer record. No premium or listing-gain estimate is shown.
Price band
₹472 – ₹496
Lot size
30 shares
Offer application amount
₹14,880
Issue size
₹839.28 Cr
Historical offer amount for 1 lot at the upper issue price. Confirm the lot size and application terms in the issuer prospectus.
Reported IPO schedule
| Open date | 25 Sept 2025 |
| Close date | 29 Sept 2025 |
| Allotment finalisation | 30 Sept 2025 |
| Refund initiation | 1 Oct 2025 |
| Shares credited to demat | 1 Oct 2025 |
| Reported listing date | 3 Oct 2025 |
Issue size
About TruAlt Bioenergy
TruAlt Bioenergy is one of the leading companies in terms of providing biofuel, and they have a strong focus on Ethanol. Moreover, they have built a strong and diverse presence in the biofuels industry. Furthermore, they also have an aim to expand Ethanol production by 600 KLPD at three locations.
Company summary supplied by FinAPI. Read the prospectus for the issuer's disclosures and audited financials.
Use of proceeds
| Funding capital expenditure towards setting- up multi-feed stock operations to pave- way for utilizing grains as an additional raw material in ethanol plant at TBL Unit 4 of 300 KLPD capacity. | 150.68 |
| Funding our working capital requirements. | 425.00 |
Offer documents and primary references
Read the issuer's offer document and any corrigenda for the full disclosures. A third-party details page is a summary; SEBI filing access does not imply an endorsement of the offer or this website.
IPO information is sourced from public feeds and shown for general information only. It is not a recommendation to apply for this or any IPO. IPOs are equity investments and carry market risk; listing gains are not guaranteed and SME IPOs are especially volatile. Grey Market Premium (GMP) is unofficial and not endorsed by SEBI or the exchanges. Equity IPOs are applied for through a demat and trading account, not through mutual fund distribution services. Read the RHP and consult a SEBI-registered investment adviser before investing.